middle.news
Genetic Signatures gains cash control as Microba deal advances
12:36pm on Thursday 8th of October, 2026 AEDT
•
Healthcare
Read Story
Genetic Signatures gains cash control as Microba deal advances
12:36pm on Thursday 8th of October, 2026 AEDT
Key Points
Operating cash outflow fell to A$1.0 million in Q1 FY2027
Cash and term deposits stood at A$20.9 million with no debt
Operating expenses fell 30% to A$4.0 million
Commercial testing commenced at Hvidovre Hospital under a 10-year agreement
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Genetic Signatures (ASX:GSS)
OPEN ARTICLE